The billionaires are ranked at the top of 5 % of Ycombinator companies with a financing of approximately $ 400 million. In June 2024, we closed the D 130 million dollars, which led to the company’s evaluation of more than one billion dollars. This financing came from the distinguished global institutional investors, including Hummingbird, Adams Street Partners, Neubleger Berman, Baillie Gifford and Premji Invest. We have developed a molecular meter for DNA that increases the accuracy of CFDNA diagnosis by more than 1000X. Our first product, Unity, is the first and only birth test that can examine an unborn child and evaluate its risks: common and severe recessive genes; Chromosomes deformities. Fetal sex and fetus antigens of one tube of blood from a pregnant mother. This greatly improves the quality of care and is on its way until it becomes the next standard of care. Our Python/Django, React/TypeScript, Terraform, AWS and many other standard tools. We are a small, but smart software team that gives priority to rapid repetition and continuous comments to develop our products. As a biotechnology company, we inherently need to work always functionally. If you enjoy this style of work, please contact!

The billionaires are ranked at the top of 5 % of Ycombinator companies with a financing of approximately $ 400 million. In June 2024, we closed the D 130 million dollars, which led to the company’s evaluation of more than one billion dollars. This financing came from the distinguished global institutional investors, including Hummingbird, Adams Street Partners, Neubleger Berman, Baillie Gifford and Premji Invest. We have developed a molecular meter for DNA that increases the accuracy of CFDNA diagnosis by more than 1000X. Our first product, Unity, is the first and only birth test that can examine an unborn child and evaluate its risks: common and severe recessive genes; Chromosomes deformities. Fetal sex and fetus antigens of one tube of blood from a pregnant mother. This greatly improves the quality of care and is on its way until it becomes the next standard of care. Our Python/Django, React/TypeScript, Terraform, AWS and many other standard tools. We are a small, but smart software team that gives priority to rapid repetition and continuous comments to develop our products. As a biotechnology company, we inherently need to work always functionally. If you enjoy this style of work, please contact!